绝经前乳腺癌中的卵巢逃生:优化激素抑制的挑战和策略
Lan Luo1, Yonglin Zhang1, Li Zhang2
1Department of Breast Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China; Guizhou Medical University, Guiyang 550004, China.
Cancer treatment reviews
|June 21, 2025
概括
使用GnRH激动剂抑制卵巢功能 (OFS) 可能在患有HR+乳腺癌的绝经前妇女中失败. 了解卵巢逃逸 (OE) 机制和风险因素对于个性化治疗策略至关重要.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 卵巢功能抑制 (OFS) 是患有激素受体阳性 (HR +) 乳腺癌的绝经前妇女的关键治疗方法.
- 淋巴激素释放激素激动剂 (GnRHa) 是OFS的主要药物.
- 一部分患者经历了不完全的雌激素抑制,称为卵巢逃逸 (OE),有可能导致治疗失败.
研究的目的:
- 在HR+乳腺癌前更年期妇女的GnRHa治疗期间系统地审查卵巢逃逸 (OE).
- 探索潜在的风险因素和OE的潜在机制.
- 确定对标准化监测和个性化管理策略的需求.
主要方法:
- 对GnRHa治疗和卵巢逃逸研究的系统文献综述.
- 对导致雌激素抑制不完全的因素的分析.
- 检查诊断挑战和建议的管理策略.
主要成果:
- 在GnRHa治疗期间的卵巢逃逸 (OE) 是绝经前乳腺癌患者的一个公认的临床问题.
- 更年期状态定义和测定方法的变化使OE诊断复杂化.
- 有证据表明,潜在的风险因素和机制需要进一步调查.
结论:
- 在OFS期间对激素监测缺乏标准化指南.
- 需要个性化策略来优化OFS的有效性并减轻OE风险.
- 对OE机制和精细的治疗方法的进一步研究将促进对高风险人群的个性化护理.
更多相关视频
11:29Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
14.4K
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
13.3K
相关概念视频
Hormonal Control of the Ovarian Cycle
3.4K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
3.4K
Oogenesis
64.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.5K
Hormonal Regulation of the Menstrual Cycle
725
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
725
